Modified CJC-1295

Modified CJC-1295 works through specific mechanisms to support health goals. Current research status: Under investigation.

Category
Metabolic Regulation
Research Status
Phase 2
Legal Status (AU)
Script Required
Dosage
196mcg daily

Mechanisms of Action

Modified CJC-1295 works through specific biological pathways to produce its effects.

GHRH agonistGhrelin mimetic

Potential Benefits

Research suggests Modified CJC-1295 may offer several therapeutic benefits:

  • increased HGH
  • muscle growth
  • fat loss

Potential Side Effects

While generally well-tolerated, Modified CJC-1295 may cause some side effects:

injection site reactionsflushing

Frequently Asked Questions

What is Modified CJC-1295?

Modified CJC-1295 is a metabolic regulation peptide that ghrh agonist. Current research status: Phase 2.

Is Modified CJC-1295 legal in Australia?

In Australia, Modified CJC-1295 is classified as: Script Required. Always consult with a healthcare professional and check current regulations.

What is the recommended dosage?

Typical dosage is 196mcg daily. However, dosing should be personalized based on individual factors and medical supervision.

Important Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any peptide therapy. Peptides may have different effects on different individuals and may interact with medications.